Pharmerit rebrands to OPEN Health
May 20, 2021 |
OPEN Health is moving to one brand to create a world-class integrated services model
Pharmerit, a global leader in Health Economics and Outcomes Research (HEOR) and Market Access, has undergone an extensive rebranding to fully integrate with OPEN Health. Since its inception in 2011, OPEN Health has expanded its expertise and global reach through mergers and organic growth to be at the forefront of the healthcare industry. It has brought together global experts from HEOR, Market Access, and medical communications, with digital at the heart of its services. OPEN Health provides unrivalled global healthcare specialist expertise to apply innovative approaches in research and communications with the purpose of improving patient outcomes and wellbeing.
“We are one of the few global agencies that can serve clients across the full product lifecycle,” commented Rob Barker, CEO of OPEN Health. “We are proud to partner with 38 of the top 40 biopharmaceutical and medical device companies, serving clients from Medical Affairs, HEOR, Market Access, and Commercial teams.”
As of April 2021, OPEN Health has moved to one brand to create a world-class integrated services model. Together, we are a global team of 750+ experts across the United States, Europe, United Kingdom, and Asia.
“I am excited to say that we have retained the very best of Pharmerit, which has supported so many clients for over 20 years. We are now uniting equivalent life science research and communications talents from around the world under the OPEN Health brand, which has a strong heritage. We will continue on our journey to deliver on our evidence and access promise with a new, dynamic, and fully integrated team of experts,” added Jeff Anderson, CEO of OPEN Health Evidence & Access.
Speaking of Pharmerit’s clients, the former co-founder of Pharmerit and current Chair of OPEN Health Evidence & Access, Marc Botteman, commented, “I am proud to say that our clients will find a vastly broadened set of capabilities under the OPEN Health brand, including the expansion of value and HEOR communication and writing, the addition of patient engagement capabilities to our patient-centered outcomes expertise, the inclusion of primary data collection capabilities, and extensive access to UK and European databases. This will allow us to combine our novel data analytics and machine learning expertise with deep commercial market access expertise across Europe.”
Over the past 12 months, OPEN Health has cemented its status as a leader in HEOR and medical communications. It has experienced 20% YTY growth, tallying 1400 customers in 90+ countries. This growth reflects the increasing need for HEOR to inform healthcare decisions and to engage with the healthcare community in innovative and personalized ways.
This content was provided by OPEN Health
Company Details
Latest Content from OPEN Health
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN X Health launches to provide data-driven creativity to the pharmaceutical industry
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
OPEN Health Appoints Steven Duryee as Chief Operating and Transformation Officer
Unlock possibilities: A Medical Affairs strategy fit for the future
Explore the key areas to include in a Medical Affairs strategy and plan that is fit for the future in our latest whitepaper.
OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
OPEN Health and Nested Knowledge announce strategic research collaboration to leverage AI technologies for evidence synthesis
OPEN Health unites patient engagement experts to transform the patient experience
OPEN Health, a preeminent global provider of consulting, HEOR and market access, patient engagement, and scientific and creative communications services, is bringing together experts in strategic patient innovation and engagement,...
The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe
Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice
Embracing the Patient Voice Within Publications
This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...
Navigating the nocebo effect through patient engagement is the key to setting patients up for success
If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.